Erin S LeBlanc1, Kristopher Kapphahn, Haley Hedlin, Manisha Desai, Nisha I Parikh, Simin Liu, Donna R Parker, Matthew Anderson, Vanita Aroda, Shannon Sullivan, Nancy F Woods, Molly E Waring, Cora E Lewis, Marcia Stefanick. 1. 1Kaiser Permanente Center for Health Research, Portland, OR 2Stanford University School of Medicine, Stanford University, Stanford, CA 3University of California, San Francisco, San Francisco, CA 4Warren Alpert Medical School and School of Public Health of Brown University, Providence, RI 5Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket, RI 6Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX 7MedStar, Washington Hospital Center, Washington, DC 8University of Washington School of Nursing, Seattle, WA 9University of Massachusetts Medical School, Worcester, MA 10Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL.
Abstract
OBJECTIVE: The aim of the study was to understand the association between women's reproductive history and their risk of developing type 2 diabetes. We hypothesized that characteristics signifying lower cumulative endogenous estrogen exposure would be associated with increased risk. METHODS: Prospective cohort analysis of 124,379 postmenopausal women aged 50 to 79 years from the Women's Health Initiative (WHI). We determined age of menarche and final menstrual period, and history of irregular menses from questionnaires at baseline, and calculated reproductive length from age of menarche and final menstrual period. Presence of new onset type 2 diabetes was from self-report. Using multivariable Cox proportional hazards models, we assessed associations between reproductive variables and incidence of type 2 diabetes. RESULTS: In age-adjusted models, women with the shortest (<30 y) reproductive periods had a 37% (95% CI, 30-45) greater risk of developing type 2 diabetes than women with medium-length reproductive periods (36-40 y). Women with the longest (45+ y) reproductive periods had a 23% (95% CI, 12-37) higher risk than women with medium-length periods. These associations were attenuated after full adjustment (HR 1.07 [1.01, 1.14] for shortest and HR 1.09 [0.99, 1.22] for longest, compared with medium duration). Those with a final menstrual period before age 45 and after age 55 had an increased risk of diabetes (HR 1.04; 95% CI, 0.99-1.09 and HR 1.08; 95% CI, 1.01-1.14, respectively) compared to those with age of final menstrual period between 46 and 55 years. Timing of menarche and cycle regularity was not associated with risk after full adjustment. CONCLUSIONS: Reproductive history may be associated with type 2 diabetes risk. Women with shorter and longer reproductive periods may benefit from lifestyle counseling to prevent type 2 diabetes.
OBJECTIVE: The aim of the study was to understand the association between women's reproductive history and their risk of developing type 2 diabetes. We hypothesized that characteristics signifying lower cumulative endogenous estrogen exposure would be associated with increased risk. METHODS: Prospective cohort analysis of 124,379 postmenopausal women aged 50 to 79 years from the Women's Health Initiative (WHI). We determined age of menarche and final menstrual period, and history of irregular menses from questionnaires at baseline, and calculated reproductive length from age of menarche and final menstrual period. Presence of new onset type 2 diabetes was from self-report. Using multivariable Cox proportional hazards models, we assessed associations between reproductive variables and incidence of type 2 diabetes. RESULTS: In age-adjusted models, women with the shortest (<30 y) reproductive periods had a 37% (95% CI, 30-45) greater risk of developing type 2 diabetes than women with medium-length reproductive periods (36-40 y). Women with the longest (45+ y) reproductive periods had a 23% (95% CI, 12-37) higher risk than women with medium-length periods. These associations were attenuated after full adjustment (HR 1.07 [1.01, 1.14] for shortest and HR 1.09 [0.99, 1.22] for longest, compared with medium duration). Those with a final menstrual period before age 45 and after age 55 had an increased risk of diabetes (HR 1.04; 95% CI, 0.99-1.09 and HR 1.08; 95% CI, 1.01-1.14, respectively) compared to those with age of final menstrual period between 46 and 55 years. Timing of menarche and cycle regularity was not associated with risk after full adjustment. CONCLUSIONS: Reproductive history may be associated with type 2 diabetes risk. Women with shorter and longer reproductive periods may benefit from lifestyle counseling to prevent type 2 diabetes.
Authors: Michal Dishi; Daniel A Enquobahrie; Dejene F Abetew; Chunfang Qiu; Carole B Rudra; Michelle A Williams Journal: Diabetes Res Clin Pract Date: 2011-08-03 Impact factor: 5.602
Authors: Chunyan He; Cuilin Zhang; David J Hunter; Susan E Hankinson; Germaine M Buck Louis; Mary L Hediger; Frank B Hu Journal: Am J Epidemiol Date: 2009-12-21 Impact factor: 4.897
Authors: K L Margolis; D E Bonds; R J Rodabough; L Tinker; L S Phillips; C Allen; T Bassford; G Burke; J Torrens; B V Howard Journal: Diabetologia Date: 2004-07-14 Impact factor: 10.122
Authors: Cathy E Elks; Ken K Ong; Robert A Scott; Yvonne T van der Schouw; Judith S Brand; Petra A Wark; Pilar Amiano; Beverley Balkau; Aurelio Barricarte; Heiner Boeing; Ana Fonseca-Nunes; Paul W Franks; Sara Grioni; Jytte Halkjaer; Rudolf Kaaks; Timothy J Key; Kay Tee Khaw; Amalia Mattiello; Peter M Nilsson; Kim Overvad; Domenico Palli; J Ramón Quirós; Sabina Rinaldi; Olov Rolandsson; Isabelle Romieu; Carlotta Sacerdote; María-José Sánchez; Annemieke M W Spijkerman; Anne Tjonneland; Maria-Jose Tormo; Rosario Tumino; Daphne L van der A; Nita G Forouhi; Stephen J Sharp; Claudia Langenberg; Elio Riboli; Nicholas J Wareham Journal: Diabetes Care Date: 2013-11 Impact factor: 19.112
Authors: Catherine Kim; Vanita R Aroda; Ronald B Goldberg; Naji Younes; Sharon L Edelstein; MaryLou Carrion-Petersen; David A Ehrmann Journal: J Clin Endocrinol Metab Date: 2018-02-01 Impact factor: 5.958
Authors: Eric K Broni; Chiadi E Ndumele; Justin B Echouffo-Tcheugui; Rita R Kalyani; Wendy L Bennett; Erin D Michos Journal: Curr Diab Rep Date: 2022-02-14 Impact factor: 4.810
Authors: Erin S LeBlanc; Kathleen M Hovey; Jane A Cauley; Marcia Stefanick; Rachel Peragallo; Michelle J Naughton; Christopher A Andrews; Carolyn J Crandall Journal: J Bone Miner Res Date: 2022-06-19 Impact factor: 6.390